繁殖性に及ぼす影響
|
|
|
- みいか よどぎみ
- 5 years ago
- Views:
Transcription
1 5. 2
2 1. (DEP) 1) DEP 2) 3) 4) DEP ppm( mg/kg/day mg/kg/day ) 24 Crj:CD(SD) IGS 2 DEP ppm F F1 F0 F1 DEP F1 F ppm ppm F0 F1 F0 F0 P-450 (CYP1A1/2 CYP2B1 CYP3A2 CYP4A1)15000 ppm CYP4A1 CYP3A2 CYP3A 6 5) F ppm DEP - 2 -
3 F1 F2 DEP ppm F F1 F2 21 F1 F2 DEP ppm F1 F2 4 F1 F2 DEP 3000 ppm F1 F ppm F1 F2 F1 F2 F2 F1 F2 F1 F1 F2 F0 F ppm ppm F0 P-450 CYP3A ppm F0 F0 F ppm F1 F ppm ppm 2 (NOEL) 3000 ppm(210 mg/kg/day 261 mg/kg/day )(NOAEL) ppm(1083mg/kg/day 1336 mg/kg/day ) 600 ppm(43 mg/kg/day 54 mg/kg/day ) 3000 ppm(210 mg/kg/day 261 mg/kg/day ) 3000 ppm - 3 -
4 600 ppm(43 mg/kg/day 54 mg/kg/day ) ppm(1083mg/kg/day 1336 mg/kg/day ) - 4 -
5 2 (DEP) 99.8 ( Lot No. SEM5441) 3 4 (NEDO) 2 5 Crj:CD(SD) IGS () 1 24 F0 5 6 F0 F ( ) 7 0, 600, ppm (NIH-07M) 8 2 ( ) 0 () ppm 1 8 Crj:CD(SD)IGS 4 F ppm ppm ppm ppm ppm ppm F ppm ppm ppm ppm
6 9 9.1 NIH-07M(H7010 H ±3 50± :00 20: W 410D 200H mm,
7 F0 15 F F1 F1 24 F F1 F F () ( ) () ( ) ()
8 10.6 ( ) ( ) (HTM-IVOS Hamilton Thorne research ) ( 200 ) 10.7 P F0 P-450 (CYP1A1/2 CYP2B1 CYP3A2 CYP4A1) P-450 F0 DPC DPC RIA ( ) ( 0 ) ( ) ( 4 0 ) ( ) ( 21 4 )
9 F0 F1 ( ) 1 F1 F2 ( ) F1 F1 F F0 F1 F1 6 F1 F2 6 F Bartlett - 9 -
10 Dunnett Kruskal-Wallis Mann-Whitney U 1 1 Wilcoxon Fisher
11 . F : ( ) ( ) ( 4 4 ) ( ) ( ) ( ) ( )
12 F0/F1 F F1 ( 1 2 F1 F1 26 ) F0 6 P ( ) 6 F :1 0 F1 2 3 ( ) ( )
13 F ( 4 4 ) ( ) ( ) ( ) ( ) F1/F2 F2 26 ( ) 1 ( )
14 - 14 -
15 Tables 1 and 2 F0F1 DEP DEP( )3000 ppmf0 1 ( ) F0 2 (1 1 ) DEP ppmf0f Tables 3 to 6 F0F ppm3000ppm F0 600 ppm ppmf0 F10-1 F00-21 F121 F1 DEP ppmf0 F Tables 7 and 8 F0F13000 ppm F ppm ppmf0f1 1 DEP DEP ppmf0f1-15 -
16 Tables 13, 14, and 16 F0F1 DEP F1 1)2. Table 13 F ppm (22 23 ) 2) 2. Table 15 F ppm F ppm Tailless DEP 3)2. Table 16 F ppm ppmf1 DEP ppm F0F Tables 21 and 22 F0F ppm3000 ppm ppmf0f1 F0 DEP ()F1 F1 DEP
17 DEP ppm F0F1 F0 DEP P Table 17 F0 P-450 (CYP1A1/2 CYP2B1 CYP3A2 CYP4A1) 3000 ppm15000 ppm CYP4A1CYP3A2 DEP P-450 CYP4A1P-450 6) 7) DEP CYP3A6 5) F0 DEP ppm P-450(CYP4A1 CYP3A2) P Table 18 F0RIA ppmcyp3a ppm ppm 8) DEP 3000 ppm CYP3A
18 2. Tables 19, 20, 23, and 24 F0F1 DEP15000 ppm DEP ppmf0 F Tables 25 and 26 F1F2DEP DEP ppmf1f Table ppmf1f2 F F1 F221 DEP ppmf1f Tables 13, 28, and 32 to 34 F1F DEP DEP ppmf1f Tables 29 to 31 F1F ppm
19 DEP ppm Tables 35 and 36 F1 F24F1 F2 F1F1 F2 DEP DEP ppm F1F Tables and 39 F1F2600 ppm F ppmf1f ppm ppmf1f2 F1F2 F1 F2 F1F2 F2 F1F2 F1 F1F2 DEP in vitro 2) in vivo 3) F1F1 F2 F1 F1 F2 DEP 3000 ppmf1f ppm F1F2 F1F2 F2 F1F2 F1 F1F2-19 -
20 11.3 NOEL F0 F ppm ppm F0 P-450 CYP3A ppm F0 F0 F ppm F1 F ppm ppm 2 (NOEL) 3000 ppm(210 mg/kg/day 261 mg/kg/day )(NOAEL) ppm(1083mg/kg/day 1336 mg/kg/day ) 600 ppm(43 mg/kg/day 54 mg/kg/day ) 3000 ppm(210 mg/kg/day 261 mg/kg/day ) 3000 ppm 600 ppm(43 mg/kg/day 54 mg/kg/day ) ppm(1083mg/kg/day 1336 mg/kg/day )
21 12. 1) 13398,,, 1998, pp ) Blair, R.M., Hong, F., William, S.B., Bruce, S.H., Stacey, L.D., Carrie, L.M., Weida, T., Leming, S., Roger, P., and Daniel, M.S. The estrogen receptor relative binding affinities of 188 natural and xenochemicals: structural diversity of ligands. Toxicol. Sci., 2000; 54: ) ) Harris, C.A., Henttu, P., Parker, M.G., Sumpter, J.P. The estrogenic activity of phthalate esters in vitro. Environ. Health Perspect., 1997; 105: ) Niwa, T., Yabusaki, Y., Honma, K., Matsuo, N., Tatsuta, K., Ishibashi, F. and Katagiri, M.: Contribution of human hepatic cytochrome P450 isoforms to regioselective hydroxylation of steroid hormones. Xenobiotica, 28, , ) Bell, D.R. and Elcombe, C.R. Induction of acyl-coa oxidase and cytochrome P450 IV A1 RNA in rat primary hepatocyte culture by peroxisome proliferators. Biochemical Journal, 280, , ) Okita, R.T. and Okita, J.R. Effects of diethyl phthalate and other plasticizers on laurate hydroxylation in rat liver microsomes. Pharmaceutical Research 9, , ). Markert, C.L., 1979:
22 2. F0() F1 F1 F2 ppm mg/kg/day /24 0/24 1/24 0/24 0/24 0/24 0/24 0/24 2/24 0/24 0/24 0/24 0/24 0/24 0/24 0/24 (g) f) [MeanS.D.] a)b) c) (g) g) d) g) e) [MeanS.D.] (g) /24 23/24 24/24 24/24 24/24 24/24 21/24 23/24 22/23 22/23 24/24 23/24 23/24 23/24 20/21 22/23 (x10 6 ) (x10 6 ) (%) (%) (g) /24 23/24 22/24 24/24 23/24 24/24 20/24 21/24 ( )() /24 23/24 24/24 24/24 24/24 24/24 23/24 24/24 23/24 22/23 24/24 23/24 23/24 23/24 22/23 23/24 22/23 22/22 24/24 22/23 23/23 23/23 22/22 23/23 () (%) a) (p0.01)b) (p0.05)c) 0-21 (p0.01)d) 910 (p0.05) e) (p0.05)f) 0-1 (p0.01)g) 1 (p0.05) p0.05 p0.01
23 2. 1 F0() F1 F1 F2 ppm a) (g) [MeanS.D.] (mg) (mg) (g) (%) (x10-3 ) (x10-3 ) (g) (g) (%) b) P-450 CYP3A (p mol/mg protein) CYP4A b) (ng/ml) p0.05 p0.01
24 2. 2 F0() F1 F1 F2 ppm (%) (g) [MeanS.D.] (mm) [MeanS.D.] /3 40.5/ / / / / / / /94.2 (, %) 10 /11 4.9/ / / / / / / / / / / / / / / / / /14 8.2/ / / / / / / / /3 39.1/ / / / / / / / / / / / / / / / / / / / / / / / / / / / / / / / / / / ( ) [MeanS.D.] p0.05 p0.01
25 2. 3 F0() F1 F1 F2 ppm a) (g) [MeanS.D.] (g) (g) (g) (mg) (mg) (mg) (mg) (mg) (x10-3 ) (x10-3 ) (x10-3 ) (x10-3 ) (x10-3 ) (g) (g) (g) (mg) (mg) (mg) (mg) (%) (x10-3 ) (x10-3 ) (x10-3 ) (x10-3 ) p0.05 p0.01
DCHP
2. 2 1. 1) 2) 2 Crj:CD(SD)IGS SPF 0 240 1200 6000 ppm 2 F0 10 F0 10 F1 21 F1 3 10 F1 3 10 F2 21 0 240 1200 6000 ppm 1 F0 0 15.88 79.57 401.8 mg/kg/day F0 0 20.80 104.19 510.7 mg/kg/day F1 0 17.84 89.89
…h…L…–…†…fi…g1
RY RO RR RW LN LM LB LC MH MG MB RD RM RG LD CW SB VR BB EB PW PY PP PG PB 0 contents WR LR MR BR DR PM SM MC CB BO 0 P P7 P P5 P9 P 0 P4 P48 P54 P60 P66 P 04 RY RO RR RW RD RM RG LN LM LB LC LD MH MG
12-7 12-7 12-7 12-7 12-8 12-10 12-10 12-10 12-11 12-12 12-12 12-14 12-15 12-17 12-18 10 12-19 12-20 12-20 12-21 12-22 12-22 12-23 12-25 12-26 12-26 12-29 12-30 12-30 12-31 12-33 12-34 12-3 12-35 12-36
h4_1_et
1 RY RO RM RG RR RW RD LN LM LB LC LD MW MG MB CW SB VR BB EB WR LR MR BR DR PM SM MC CB BO 2 3 RY RO RR RW RD RM RG LN LM LB LC LD MW MG MB 4 CW SB VR BB EB 5 PI PY PP PG PB 6 WR LR MR BR DR 7 SM MC CB
取扱説明書 ［F-02F］
F-02F 4. 2 3 4 5 6 7 8 9 0 2 3 4 5 6 7 8 a b c d a b c d a b cd 9 e a b c d e 20 2 22 ab a b 23 a b 24 c d e 25 26 o a b c p q r s t u v w d h i j k l e f g d m n a b c d e f g h i j k l m n x 27 o
福岡大学人文論叢47-3
679 pp. 1 680 2 681 pp. 3 682 4 683 5 684 pp. 6 685 7 686 8 687 9 688 pp. b 10 689 11 690 12 691 13 692 pp. 14 693 15 694 a b 16 695 a b 17 696 a 18 697 B 19 698 A B B B A B B A A 20 699 pp. 21 700 pp.
14 12 10 8 6 4 2 0 1 2 3 4 5 6 7 8 9 10 11 12 20 0 0 0 0 0 0 0 0 0 0 0 0 21 0 0 0 0 0 0 0 0 0 0 0 0 22 0 0 0 0 0 0 0 0 0 0 0 0 23 0 0 0 0 0 0 0 0 0 0 0 0 24 0 0 0 0 0 0 0 0 0 0 0 0 25 0 0 0 0 0 0 0 0 0
() 2
1 () 2 2 4 3 6,500 4 5 2 6 A B A B A B A B - A B 7 8 A B A B A B 9 JR JR 10 11 6 5 12 17 6 13 14 B A A B A B A B 2 1 8 15 8 16 17 9 18 3 4 5 mm mm 19 2 20 3 6 7 11 12 13 14 18 4 3 2 1 21 3 12 13 14 16
PowerPoint プレゼンテーション
40 6 Fischer 2 McNemar 2 No Yes No Yes Mann Whitney s U Wilcoxon 1 Kruskal Wallis 2 Friedman No Yes 2 Yes No Yes Bonferroni ANOVA No Scheffe Yes Student s T No Paired T Welch s T 40 6 Fischer 2 McNemar
% 1% SEM-EDX - X Si Ca SEM-EDX SIMS ppm % M M T 100 % 100 % Ba 1 % 91 % 9 % 9 % 1 % 87 % 13 % 13 % 1 % 64 % 36 % 36 % 1 % 34 46
Review on Hair Analysis in the Wakayama Arsenic Case Jun KAWAI Department of Materials Science and Engineering, Kyoto University Sakyo-ku, Kyoto 606-8501, Japan Received 6 December 2014, Revised 29 December
CTD 2 2.6 5.3mg 0.4mg 0.6mg 0.8mg 1.0mg 1.2mg 1.4mg 1.6mg 1.8mg 2.0mg 12mg 2.6 Page 3 2.6.6...5 2.6.6.1...6 2.6.6.2...9 2.6.6.3...9 2.6.6.4... 11 2.6.6.5... 11 2.6.6.6... 11 2.6.6.7... 11 2.6.6.8... 11
14 4 12 10 8 6 3 2 4 2 1 0 0 100200300400500600 100200300400500600700 0 0 100200300400500600 100200300400500600700 (ppm) (ppm) 7 4 6 5 4 3 3 2 2 1 1 0 0 100200300400500600 100200300400500600700 0 0 100200300400500600
untitled
b 0 1PPm 10PPm 100PPm 1000PPm 10000PPm 0.0001% 0.001% 0.01% 0.1% 1% 10% 1PPm 10PPm 100PPm 1000PPm 10000PPm 0.0001% 0.001% 0.01% 0.1% 1% 10% 1PPm 10PPm 100PPm 1000PPm 10000PPm 0.0001% 0.001% 0.01%
ニトロトルエン
4-115 116 4-3 2 117 4- g/kg/day mg/kg/day 25 125 30 40 50 100 250 300 ( ) ( ) ( ) ( ) F1 42 10 118 ER 10-11 M 1% 10-11 10-4 M ER 10-4 M 3% 10-11 10-4 M E-screen 10-9 10-4 M AR ( ) 10-6 10-4 M AR ( ) 10-6
- 108 -
3-107- - 108 - 3.1 3.1.1 3.1.2 3.1.2.1 5 LD50 LC50 ATE 3.1.1 1 2 3 4 5 (mg kg ) 5 50 300 2000 5000 a (mg kg ) 50 200 1000 2000 a (ppm) 100 500 2500 5000 a b mg 0.5 2.0 10 20 a b c d 0.05 0.5 1.0 5 (mg
橡H1102答申別添1.PDF
1993 10mg/ Walton 1951 WHO 1993 1992 Walton American Journal of Public Health 41 1951 10ppm 10mgN/, 50mg/ 1993 1990 1997 10 HAN TEAN HAN 61%, TEAN19%, 20% WHO FAO JECFA 0, 0.1, 1, 5, 10% 5 NOEL % 500mg/kg/day
総合薬学講座 生物統計の基礎
2013 10 22 ( ) 2013 10 22 1 / 40 p.682 1. 2. 3 2 t Mann Whitney U ). 4 χ 2. 5. 6 Dunnett Tukey. 7. 8 Kaplan Meier.. U. ( ) 2013 10 22 2 / 40 1 93 ( 20 ) 230. a t b c χ 2 d 1.0 +1.0 e, b ( ) e ( ) ( ) 2013
BIT -2-
2004.3.31 10 11 12-1- BIT -2- -3-256 258 932 524 585 -4- -5- A B A B AB A B A B C AB A B AB AB AB AB -6- -7- A B -8- -9- -10- mm -11- fax -12- -13- -14- -15- s58.10.1 1255 4.2 30.10-16- -17- -18- -19-6.12.10
取扱説明書 ［F-02F］
F-02F 3. 2 3 4 5 6 7 8 9 0 2 3 4 5 6 7 8 a b c d a b c d 9 a b cd e a b c d e 20 2 22 ab a b 23 24 a c b 25 d e 26 o a b c p q r s t u d h i j k l e f g d m n a b c d e f g h i j k l m n v 27 o P P
近畿中国四国農業研究センター研究報告 第７号
230 C B A D E 50m 558 0 1km (mg L 1 ) T N NO 2 3 N NH 4 N 2.0 0 (a) 2001 1.5 6 20 21 5 1.0 0.5 0.0 2.0 1.5 1.0 0.5 0.0 14:00 17:00 (b) 2001 7 3 4 20:00 23:00 2:00 (h) 5:00 8:00 11:00 10 0 5 10 15
Microsoft Word - 表紙資料２－４
(1) / 130 g 25 g 520% 170 g 30 g 560% 70 mg 600 mg 11.6% 0 10.5 mg 0% (1) (2) / 50100 g 25 g 200400% 50100 g 30 g 167333% 5001000 mg 600 mg 83167% 1020 mg 10.5 mg 95190% (2) / (1) 45.6 g 30 g 152% (2)
(1) (2) (1) (2) (1) Seg (2) Seg (3) Seg (4) Seg (1) (2) (3) ( ) (1) (PCA)...12
(1)...109 (2)...110 (1) 28...111 (2) 28...113 (1) Seg...115 (2) Seg...117 (3) Seg...119 (4) Seg...120 (1)...122 (2)...122 (3) ( )...126 (1) (PCA)...127 (2) Draize...128 (1) Ames...129 2 in vitro...132
67.5km 299.4km 2 2 2 16km 1/6 47km 2 1 1 (m) (km 2 ) 2,700 7.6 9,927 47.1 8,100 13.4 8,120 4.8 52 0.4 1,100 6.0 2,200 3.8 6,982 45.3 4,473 14.4 5,000 9.5 2 (km 2 ) (km) 1 299.4 67.5 2 284.5 38.8 3 267.0
98-02.PDF
1 982 2207 CAS 67630 2- H 3 C H 3 C CH OH C 3 H 8 O 60.10 1 99.9 % n- 1. 2-88.5 3 82.5 3 11.7c.c. 455 4 212 d 20 4 0.78505 3 2.1 = 1 4 4.4 kpa 33 mmhg20 4 log Pow0.05 0.07 5 m/z45, 1.0 43 0.19 27 0.17
パソコン接続マニュアル P-01F 日本語
P-01F 1 2 3 4 5 1 2 +m1111 1 2 3 4 5 6 6 1 1 111 2 1 3 1 1 1 2 1 7 3 8 1 2 1 111 3 4 5 9 1 m111 m1111 c 2 3 4 5 10 1 1 111 2 1 3 1 1 1 2 1 3 1 m111 m1111 2 3 1 11 12 1 2 3 1 2 3 13 1 2 3 4 5 14 6 7 8 9
MH MH 9.50 8.50 9.40 8.40 9.30 9.20 8.30 9.10 9.00 8.20 8.90 8.80 8.10 8.70 8.60 8.00 8.50 7.90 8.40 8.30 7.80 8.20 8.10 7.70 8.00 7.60 7.90 7.80 7.50 7.70 7.60 7.40 1 7.50 7.40 7.30 2 7.30 7.20 7.20
参考資料５ 農薬評価書 メタアルデヒド（食品安全委員会資料）
1 3 3 4 5. 6 1. 6 2. 6 3. 6 4. 6 5. 6 6. 6 7. 6. 7 1. 7 2. 8 (1) 8 (2) 9 (3) 9 (4) 10 (5) 10 3. 11 (1) 11 (2) 11 (3) 11 (4) 12 4. 12 (1) 12 (2) 12 (3) 13 5. 13 6. 13 7. 14 8. 15 9. 16 10. 16 (1) 90 16-1
CAS NC(CH 2 ) 4 CN 1,4- C 6 H 8 N c.c d = Pa
1 200117 21512 CAS 111693 110 NC(CH 2 ) 4 CN 1,4- C 6 H 8 N 2 108.14 1 99 2-1. 2 1 295 159 c.c. 550 3 1.7-4.9 20 d 0.965 4 3.73 = 1 0.3 Pa 0.002 mmhg20 2 log Pow-0.32 m/z 41, 1.0 68 0.54 54 0.43 4 Koc9-16
[RP13]シリーズカタログ
![[RP13]シリーズカタログ](/thumbs/99/140027433.jpg "[RP13]シリーズカタログ")
131520 : : : 2AAWG#24 : 2AAWG#22 1315 : AC30VDC42V 20 : AC100VDC140V 1. 1315 : 15m 20 : 30m DC1A -10 ~ +60-10 ~ +60 2. 1000M DC250V 3. AC300V1 4. 10s 10~55Hz/0.75mm 32 5. 10s 490m/s 2 11ms33 6. 7. 1315
取扱説明書 ［F-01F］
F-0F 3.0 2 3 4 5 6 7 8 9 0 2 3 4 5 6 7 8 9 20 a b c d a b c 2 d 22 a b cd e a b c d e 23 24 25 26 a b a b 27 28 b a 29 c d 30 r s t u v w x a b c e f g d h n i j k l m a b o c d p e f g h i j k q l
0774 CAS No. 111-15-9 2014 3 25 0774 1 3 1 3 11 3 12 3 13 3 2 3 3 4 31 4 32 4 4 4 5 1 5 11 5 12 5 13 5 14 5 15 5 16 6 17 6 2 7 21 7 22 7 23 7 1 7 2 8 3 8 3 8 31 8 32 9 33 9 34 9 35 9 36 9 37 10 1 10
-------------------------------------------------------------------------------------------------- 1 ----------------------------------------- 3 --------------------------------------------------------------------------------
46 29 12 47 48 28 10 3 49 -17- S53 288.67 100 -- S53 328.11 40-23-12 S56 372.77 40 -- S62 304.99 40-12-10 S57 202.57 100 --16 S58 368.52 40 -- S59 396.31 100-14-13 S63 307.98 40 --20 S60 337.60 40 --
Isotope News 2017年10月号 No.753
Ishioka Noriko ₁ はじめに RI RI RI RI ₂ 悪性褐色細胞腫と治療の現状 3,000 90 I meta- Iiodo-benzylguanidine I-MIBG 1 ₃ α 線の標的アイソトープ治療 2016 6 223 RaCl2 223 Ra 223 Ra 14 表 1 α 線と β 線の違い -decay (42%) Eα = 5.9 MeV At 7.2 h EC
05避難シミュレーション編.PDF
1....5-2 1.1...5-2 1.2...5-2 1.3...5-4 1.4...5-5 1.5...5-8 1.6...5-8 1.7...5-9 1.8...5-19 2....5-21 5-1 5-2 ) ( ) / ( ) / ( ) ( 2 ( ) ( ) 5-3 1-1 5-4 ( 17 3 ) 1 ( 1) 1-2 ( )2 3 ( 5 ) 5 1 5 ( ) ( ) 1-2
市区長選挙における民主党の戦略
. , -,,, a, .......................................................... -,,, b b .............................. .. ,. %,,,,, JR TUBE TUBE TUBE TUBE ,. %,,,,,,,,,,,,,,,,,,,, ,. %,,, a, b - - -- pp a b
I
I II 1 2 3 4 5 6 7 8 9 10 11 Rp.1) 50mg 3 3 14 Rp.2) 2.5mg 2 14 Rp.1) 2.5mg 3 2 2:1 14 Rp.) 15g 1 3 28 Rp.2) 50 600mg 1 2 28 12 Rp.1) CR 20mg 1 1 1 14 Rp.2) R 200 1 2 14 Rp.3) 3 1 3 14 Rp.1) 2.5mg 0.4
17 18 2
17 18 2 18 2 8 17 4 1 8 1 2 16 16 4 1 17 3 31 16 2 1 2 3 17 6 16 18 1 11 4 1 5 21 26 2 6 37 43 11 58 69 5 252 28 3 1 1 3 1 3 2 3 3 4 4 4 5 5 6 5 2 6 1 6 2 16 28 3 29 3 30 30 1 30 2 32 3 36 4 38 5 43 6
t 492 t mg/l 30 mg/l BOD 95 OH = cm 3 / sec 25 8 OH /cm 3 12 = ph ph
2-1 200169 2740 CAS 110-49-6 1103 2- O H 3 C C O CH 2 CH 2 O CH 3 C 5 H 10 O 3 118.13 200168 2-1 99 2-1. 2 2, 3-65 2, 3 144145 45 o.c. 3 392 3 1.512.3 d19 1.009 2 4.07 = 1 30 Pa 0.23 mmhg20 2 4 log Pow0.10
![かんたん操作ガイド[arrows M02]](/thumbs/39/20071242.jpg "かんたん操作ガイド[arrows M02]")
![かんたん操作ガイド[arrows RM02]](/thumbs/39/20475147.jpg "かんたん操作ガイド[arrows RM02]")
![かんたん操作ガイド[arrows M03]](/thumbs/42/22941141.jpg "かんたん操作ガイド[arrows M03]")
◎⑥BBP報告書_委員会当日_20030626
4-6 6. 2-1 - 1. (BBP) ( ) 1) BBP 2) 3) 4) 3),4) 5),6) 7),8) + 7) BBP 0 100 200 400 mg/kg/day 24 Crj:CD(SD) IGS 2 F0 200 mg/kg F1 100 mg/kg F0 F1 BBP 400 mg/kg F0 F1 F0 F1 BBP F1 400 mg/kg F1 F0 BBP 200
EPSON エプソンプリンタ共通 取扱説明書 ネットワーク編
K L N K N N N N N N N N N N N N L A B C N N N A AB B C L D N N N N N L N N N A L B N N A B C N L N N N N L N A B C D N N A L N A L B C D N L N A L N B C N N D E F N K G H N A B C A L N N N N D D
ありがとうございました
- 1 - - 2 - - 3 - - 4 - - 5 - 1 2 AB C A B C - 6 - - 7 - - 8 - 10 1 3 1 10 400 8 9-9 - 2600 1 119 26.44 63 50 15 325.37 131.99 457.36-10 - 5 977 1688 1805 200 7 80-11 - - 12 - - 13 - - 14 - 2-1 - 15 -
EPSON エプソンプリンタ共通 取扱説明書 ネットワーク編
K L N K N N N N N N N N N N N N L A B C N N N A AB B C L D N N N N N L N N N A L B N N A B C N L N N N N L N A B C D N N A L N A L B C D N L N A L N B C N N D E F N K G H N A B C A L N N N N D D
公務員人件費のシミュレーション分析
47 50 (a) (b) (c) (7) 11 10 2018 20 2028 16 17 18 19 20 21 22 20 90.1 9.9 20 87.2 12.8 2018 10 17 6.916.0 7.87.4 40.511.6 23 0.0% 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 2.0% 4.0% 6.0% 8.0%
Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4 A B (A/B) 1 1,185 17,801 6.66% 2 943 26,598 3.55% 3 3,779 112,231 3.37% 4 8,174 246,350 3.32% 5 671 22,775 2.95% 6 2,606 89,705 2.91% 7 738 25,700 2.87% 8 1,134
橡hashik-f.PDF
1 1 1 11 12 13 2 2 21 22 3 3 3 4 4 8 22 10 23 10 11 11 24 12 12 13 25 14 15 16 18 19 20 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 144 142 140 140 29.7 70.0 0.7 22.1 16.4 13.6 9.3 5.0 2.9 0.0
198
197 198 199 200 201 202 A B C D E F G H I J K L 203 204 205 A B 206 A B C D E F 207 208 209 210 211 212 213 214 215 A B 216 217 218 219 220 221 222 223 224 225 226 227 228 229 A B C D 230 231 232 233 A
ネットショップ・オーナー２ ユーザーマニュアル
1 1-1 1-2 1-3 1-4 1 1-5 2 2-1 A C 2-2 A 2 C D E F G H I 2-3 2-4 2 C D E E A 3 3-1 A 3 A A 3 3 3 3-2 3-3 3-4 3 C 4 4-1 A A 4 B B C D C D E F G 4 H I J K L 4-2 4 C D E B D C A C B D 4 E F B E C 4-3 4
1
1 2 3 4 5 (2,433 ) 4,026 2710 243.3 2728 402.6 6 402.6 402.6 243.3 7 8 20.5 11.5 1.51 0.50.5 1.5 9 10 11 12 13 100 99 4 97 14 A AB A 12 14.615/100 1.096/1000 B B 1.096/1000 300 A1.5 B1.25 24 4,182,500
05[ ]戸田(責)村.indd
![05[ ]戸田(責)村.indd](/thumbs/91/106164845.jpg "05[ ]戸田(責)村.indd")
147 2 62 4 3.2.1.16 3.2.1.17 148 63 1 3.2.1.F 3.2.1.H 3.1.1.77 1.5.13 1 3.1.1.05 2 3 4 3.2.1.20 3.2.1.22 3.2.1.24 3.2.1.D 3.2.1.E 3.2.1.18 3.2.1.19 2 149 3.2.1.23 3.2.1.G 3.1.1.77 3.2.1.16 570 565 1 2
/9/ ) 1) 1 2 2) 4) ) ) 2x + y 42x + y + 1) 4) : 6 = x 5) : x 2) x ) x 2 8x + 10 = 0
1. 2018/9/ ) 1) 8 9) 2) 6 14) + 14 ) 1 4 8a 8b) 2 a + b) 4) 2 : 7 = x 8) : x ) x ) + 1 2 ) + 2 6) x + 1)x + ) 15 2. 2018/9/ ) 1) 1 2 2) 4) 2 + 6 5) ) 2x + y 42x + y + 1) 4) : 6 = x 5) : x 2) x 2 15 12
2 1 7 - TALK ABOUT 21 μ TALK ABOUT 21 Ag As Se 2. 2. 2. Ag As Se 1 2 3 4 5 6 7 8 9 1 1 2 3 4 5 6 7 8 9 1 1 2 3 4 5 6 7 8 9 1 Sb Ga Te 2. Sb 2. Ga 2. Te 1 2 3 4 5 6 7 8 9 1 1 2 3 4 5 6 7 8 9 1 1 2 3 4
ズームインNo.22（要約版・0608)
21 5 500 600 08 2030 10 40 35 50 21 21 25 5 21 500 600 10 0 08 10 1 2008 79 3.6 06 13 5.4 3 2 08 79 04 8 06 08 08 2030 10 40 50 3 1 .jp 08 835 Pro 35 5 35 35 08 10 35S 1 5 0.3 09 1 35 1 08 11 08 12 50
(2009) 1... / 1 ( ) / 1 ( ) / 1 ( ), 2 ( )
212009................................................ 2............................................ 115 (2009) 1... / 1 ( )........................................... 4 2... / 1 ( )......................................
卓球の試合への興味度に関する確率論的分析
17 i 1 1 1.1..................................... 1 1.2....................................... 1 1.3..................................... 2 2 5 2.1................................ 5 2.2 (1).........................
C033** of 7 C034** PEG-IFN-2b + IFN -2b + 78 HCV-RNA PEG-IFN-2b IFN-2b n=250 n=200 n= =10 % % 85 % 74 % %
2.7.6.9 2.7.6.9.1 Genotype 1 C PEG-IFN-2b+ C033* Genotype 1 C PEG-IFN-2b + IFN-2b + 2.7.6-54 2.7.6-54 C033* 1 of 7 Genotype 1 C PEG-IFN-2b+ Genotype 1 C PEG-IFN-2b + IFN-2b + 24 HCV-RNA 48 24 follow-up
() 1 1 2 2 3 2 3 308,000 308,000 308,000 199,200 253,000 308,000 77,100 115,200 211,000 308,000 211,200 62,200 185,000 308,000 154,000 308,000 2 () 308,000 308,000 253,000 308,000 77,100 211,000 308,000
地域再生計画
22 6,491ha 80 5,244ha 85.7 5,540ha 50km1 10,793 H17.5.1 15 35 51.7 1,943 1 50 9.5 351 12 2.4 130 2 16 13 5 14 1,545 1,019 35 1 20 10 3 15 3 3 H17.5.1 282 99 130 15 3 15 3 11 2 20 H16.12. 3 50km JR 9 4
１
10 2 1990 5 1993 6 16 11 24 18 35 1960 41 1966 19 2 11 14 30 1955 10 41 1966 12 16 45 40 35 2004 2004 2004 30 25 20 15 10 5 0 1950 1960 1970 1980 1990 2000 6 10 1 6 46 10 2223 2 6 10 6 10 1 6 7 8 1011
,977 t 157,977 t mg l mg l BOD 9398 % OH = cm 3 / sec 11 = cm 3 / sec OH = /
1 9625 2219 CAS 75569 1, 2-1, 2- H 2 C CH CH 3 C 3 H 6 O 58.08 1 99 % 1. 2 2, 3-112.13 2, 3 34.23-37 449 2.8-37 % 2 d 0 4 0.859 4 d 20 0.8304 2 2, 4 2.00 = 1 53.33 kpa 400 mmhg18 59.33 kpa 445 mmhg20 5
A B C A B C X Y Z
Argonauta 8: 27-37 (2003) 1 ANOVA, analysis of variance t 1980 90 ANOVA ANOVA Underwood, 1997 ANOVA ANOVA ANOVA 1975 Sokal & Rohlf 1981 1990 Underwood 1997 1997 Zar 1999 1-way ANOVA 2-way, 3-way, ANOVA,
資料１(目消し版).ppt
1 Dr. Grandjean 2 15 45 3 4 CH 3 Hg + Hg 0 fi Hg ++ fich 3 + MeHg MeHg 5 Methylmercury-2 6 :, A. Yasutake 7 - A. Yasutake 8 :,. A. Yasutake 9 A. Yasutake 10 (%) : : : : : MeHg 0.05 250 : 2 : 1 : 0.1 :
CAS O C O * DOP* DEHP 2- C O O * n- C 24 H 38 O CH 2 CH 2 CH 2 CH 3 CH (CH 2 ) % 2- A BHT , 4
2-1 9628 31307 CAS 117817 2- O C O * DOP* DEHP 2- C O O * n- C 24 H 38 O 4 390.56 CH 2 CH 2 CH 2 CH 3 CH (CH 2 ) 3 1 99 % 2- ABHT 1. 2-55 3 3, 4 386 171 350 6 0.1 % d 20 4 0.9861 4 13.48 0.30410-4 Pa 2.2810-7
日経テレコン料金表（2016年4月）
1 2 3 4 8,000 15,000 22,000 29,000 5 6 7 8 36,000 42,000 48,000 54,000 9 10 20 30 60,000 66,000 126,000 166,000 50 100 246,000 396,000 1 25 8,000 7,000 620 2150 6,000 4,000 51100 101200 3,000 1,000 201
73 p.1 22 16 2004p.152
1987 p.80 72 73 p.1 22 16 2004p.152 281895 1930 1931 12 28 1930 10 27 12 134 74 75 10 27 47.6 1910 1925 10 10 76 10 11 12 139 p.287 p.10 11 pp.3-4 1917 p.284 77 78 10 13 10 p.6 1936 79 15 15 30 80 pp.499-501
122011pp.139174 18501933
122011pp.139174 18501933 122011 1850 3 187912 3 1850 8 1933 84 4 1871 12 1879 5 2 1 9 15 1 1 5 3 3 3 6 19 9 9 6 28 7 7 4 1140 9 4 3 5750 58 4 3 1 57 2 122011 3 4 134,500,000 4,020,000 11,600,000 5 2 678.00m
2 2 3 4 5 5 2 7 3 4 6 1 3 4 7 4 2 2 2 4 2 3 3 4 5 1932 A p. 40. 1893 A p. 224, p. 226. 1893 B pp. 1 2. p. 3.
1 73 72 1 1844 11 9 1844 12 18 5 1916 1 11 72 1 73 2 1862 3 1870 2 1862 6 1873 1 3 4 3 4 7 2 3 4 5 3 5 4 2007 p. 117. 2 2 3 4 5 5 2 7 3 4 6 1 3 4 7 4 2 2 2 4 2 3 3 4 5 1932 A p. 40. 1893 A p. 224, p. 226.
29 2011 3 4 1 19 5 2 21 6 21 2 21 7 2 23 21 8 21 1 20 21 1 22 20 p.61 21 1 21 21 1 23
29 2011 3 pp.55 86 19 1886 2 13 1 1 21 1888 1 13 2 3,500 3 5 5 50 4 1959 6 p.241 21 1 13 2 p.14 1988 p.2 21 1 15 29 2011 3 4 1 19 5 2 21 6 21 2 21 7 2 23 21 8 21 1 20 21 1 22 20 p.61 21 1 21 21 1 23 1
Microsoft Word - 映画『東京裁判』を観て.doc
1 2 3 4 5 6 7 1 2008. 2 2010, 3 2010. p.1 4 2008 p.202 5 2008. p.228 6 2011. 7 / 2008. pp.3-4 1 8 1 9 10 11 8 2008, p.7 9 2011. p.41 10.51 11 2009. p. 2 12 13 14 12 2008. p.4 13 2008, p.7-8 14 2008. p.126
